Advertisement

Most Recent

image: Arrested Development Makes for Long-Lived Worms

Arrested Development Makes for Long-Lived Worms

By | June 23, 2014

Starvation suspends cellular activity in C. elegans larvae and extends their lifespan. 

0 Comments

image: Week in Review: June 16–20

Week in Review: June 16–20

By | June 20, 2014

Early Neanderthal evolution; developing antivirals to combat polio; the mouth and skin microbiomes; insect-inspired, flight-stabilizing sensors

0 Comments

image: Opinion: Thwarting Medical Tourism

Opinion: Thwarting Medical Tourism

By | June 17, 2014

It’s time to take a strong stance against unregistered cellular therapies, which can undermine legitimate research efforts.

0 Comments

image: Interactome Analysis

Interactome Analysis

By | June 17, 2014

Study examines tissue-specific protein interactions linked to hereditary diseases.

0 Comments

image: To Finish Off Polio

To Finish Off Polio

By | June 17, 2014

Along with vaccination, antiviral drugs could play a key role in the eradication of poliovirus, but it’s unclear whether today’s candidate therapies will withstand the challenges of the clinic.

0 Comments

image: EMA Gearing Up for Transparency

EMA Gearing Up for Transparency

By | June 16, 2014

The European Medicines Agency is preparing for a new policy that will release rarely-seen clinical trial reports for independent scrutiny.  

0 Comments

image: Beneficial Brew

Beneficial Brew

By | June 1, 2014

Drinking green tea appears to boost the activity of DNA repair enzymes.

0 Comments

image: Week in Review: May 26–30

Week in Review: May 26–30

By | May 30, 2014

Human proteome cataloged; island-separated crickets evolved silence; molecule shows promise for combatting coronaviruses; study replication etiquette; another call for STAP retraction

0 Comments

image: Spotlight on the Cytoskeleton

Spotlight on the Cytoskeleton

By | May 27, 2014

Technique allows researchers to see the inner workings of cellular scaffolding molecules actin and tubulin.

0 Comments

image: Geron hESC Trial to Resume?

Geron hESC Trial to Resume?

By | May 27, 2014

Nearly three years after Geron shuttered its stem cell program, BioTime receives funding to relaunch a Phase 1 trial for spinal cord injury.

0 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
HIWIN
HIWIN
Advertisement
The Scientist
The Scientist
Life Technologies